cognitive changes in Parkinson's Disease and related movement disorders, behaviours, biomarkers, neuroimaging interventions, the overlap between cognition and mobility in aging and age-related neurodegenerative disease, MRI, gait, cohort studies, mild cognitive impairment, dementia, Parkinson's disease, parkinsonism, vascular risk factors
Development of biomarker (clinical, genetic, imaging, -omic) predictors of cognitive decline in aging and degenerative disorders.
Roles and Connections
Most Cited Publications
|Montero-Odasso MM, Sarquis-Adamson Y, Speechley M, Borrie MJ, Hachinski VC, Wells J, Riccio PM, Schapira M, Sejdic E, Camicioli RM, Bartha R, McIlroy WE, Muir-Hunter S, "Association of Dual-Task Gait With Incident Dementia in Mild Cognitive Impairment: Results From the Gait and Brain Study." JAMA neurology 74,7 (2017 Jul 1): 857-865|
|Mirelman A, Bonato P, Camicioli R, Ellis TD, Giladi N, Hamilton JL, Hass CJ, Hausdorff JM, Pelosin E, Almeida QJ, "Gait impairments in Parkinson's disease." The Lancet. Neurology 18,7 (2019 Jul): 697-708|
|Michielse S, Coupland N, Camicioli R, Carter R, Seres P, Sabino J, Malykhin N, "Selective effects of aging on brain white matter microstructure: a diffusion tensor imaging tractography study." NeuroImage 52,4 (2010 Oct 1): 1190-201|